Kiora Pharmaceuticals, Inc.
Q4 2021 13F Holders
Symbol
KPRX
CUSIP
49721T101
Type
Equity
Class
COMMON STOCK
Num filings
14
Total reported value, excl. options
$1.22 M
Compare 2021 Q4 to
2022 Q2
2022 Q1
Manager
Report Date
Value ($000)
Shares
Option Type